About Clindataceutics
Clindataceutics is a company. It operates as a B2B and Consulting Services. The company has 6 employees as of March 31, 2022. Clindataceutics offers products and services including Clinical Trial Management, Data and Analysis Services, CDISC Consulting, Regulatory Services, and Medical Writing. Clindataceutics operates in a competitive market with competitors including Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others.
- Employees 6 as on 31 Mar, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Clindataceutics Private Limited
- Date of Incorporation 22 Feb, 2018
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$23.97 K (USD)-0.12as on Mar 31, 2022
-
Net Profit
-$8.54 K (USD)-215.84as on Mar 31, 2022
-
EBITDA
-$11.43 K (USD)-234.89as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
6
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Clindataceutics
Clindataceutics offers a comprehensive portfolio of products and services, including Clinical Trial Management, Data and Analysis Services, CDISC Consulting, Regulatory Services, and Medical Writing.
Manages phases II to IV trials for drug development.
Provides biostatistics and clinical data handling.
Offers standards for clinical data interchange.
Assists with regulatory submissions and approvals.
Prepares reports and documents for trials.
Funding Insights of Clindataceutics
Detailed funding history for Clindataceutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Clindataceutics
Investment portfolio details for Clindataceutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Clindataceutics
Detailed financials for Clindataceutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Clindataceutics Comparisons
Peer comparison for Clindataceutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Clindataceutics
Clindataceutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of drug discovery and preclinical development services
|
|
| Locked | Locked | Locked |
Data analysis and statistical solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
Provider of laboratory tests for physicians
|
|
| Locked | Locked | Locked |
Provider of clinical research, development, and commercialization services for life sciences
|
|
| Locked | Locked | Locked |
Early drug development services are provided for pharma firms.
|
|
| Locked | Locked | Locked |
Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices
|
Detailed competitors of Clindataceutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Clindataceutics
Complete news archive for Clindataceutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clindataceutics
As of Mar 31, 2022, the latest employee count at Clindataceutics is 6.
Annual revenue of Clindataceutics is $23.97K as on Mar 31, 2022.
Clindataceutics delivers specialized services in clinical research, including trial management, data analysis, and CDISC compliance. They handle biostatistics, statistical programming, and medical writing to support drug development. Operating from India, USA, and Canada, they assist clients with regulatory submissions and innovative medicine processes through experienced teams.
Clindataceutics's top competitors include LabCorp, Charles River Laboratories and Cytel.
Clindataceutics offers Clinical Trial Management, Data and Analysis Services, CDISC Consulting, Regulatory Services, and Medical Writing.